Quote this publication Share Print

VISANNE

-
Opinions on drugs - Posted on Mar 15 2012

Reason for request

Inclusion on the list of medicines reimbursed by National Health Insurance and approved for hospital use.

-


Clinical Benefit

Substantial

The actual benefit of this proprietary medicinal product is substantial.


Clinical Added Value

no clinical added value

VISANNE does not provide an improvement in actual benefit (IAB V) in the therapeutic strategy for endometriosis.


Contact Us

Évaluation des médicaments

See also